Development and Internal Validation of a Clinical Prediction Model for Individualized Dosing of BAY 81-8973, A Full-Length Recombinant Factor VIII, in Pediatric Patients with Haemophilia A
Thrombosis research（2023）
Key words
Factor VIII,Haemophilia A,Pediatric patients,Population pharmacokinetics,Model-informed precision dosing
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined